Condition: Chronic Pain · Sponsor: Staci Gruber, Ph.D.
This study is a clinical trial of a high-cannabidiol (CBD) sublingual product compared to placebo for 9 weeks in patients with chronic pain conditions. The study will assess the impact of CBD on chronic pain symptoms, conventional medication use, clinical state, quality of life, cognition, and biomarkers.
This description comes directly from the study's public registry record.
Staci Gruber, Ph.D. · 617-855-2762 · gruber@mclean.harvard.edu
Rosie Smith, M.S. · 617-855-3338 · cbdstudy@mclean.harvard.edu
Always discuss trial participation with your own doctor first.
| McLean Hospital | Belmont, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03984565